Insights into targeting colon cancer cell fate at the level of proteoglycans / glycosaminoglycans

Current Medicinal Chemistry

Volumn 19, Issue 25, 2012, Pages 4247-4258

  Nikitovic, D ^a   Chatzinikolaou, G ^a   Tsiaoussis, J ^a   Tsatsakis, A ^a   Karamanos, N K ^b   Tzanakakis, G N ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Chondroitin sulfate; Colorectal cancer; Glycosaminoglycans; Heparan sulfate; Hyaluronan; Metastasis; Proteoglycans; Therapeutic targets; Tumor cell signaling

Indexed keywords

CD44V ANTIGEN; CHONDROITIN; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HERMES ANTIGEN; HYALURONIC ACID; PROTEOGLYCAN; RECEPTOR; RECEPTOR FOR HYALURONAN MEDIATED MOTILITY; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CANCER CELL; CANCER GROWTH; CELL ADHESION; CELL GROWTH; CELL MIGRATION; COLON CANCER; COLON MUCOSA; COLORECTAL CANCER; GENE EXPRESSION; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; INTESTINE EPITHELIUM CELL; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CHONDROITIN SULFATES; COLON; COLONIC NEOPLASMS; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; HUMANS; HYALURONIC ACID; MOLECULAR TARGETED THERAPY; PROTEOGLYCANS; SIGNAL TRANSDUCTION;

EID: 84866673728     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712802884268     Document Type: Article

References (167)

1. Rescigno, M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol., 2011, 32, 256-264
2. Iizuka, M.; Konno, S. Wound healing of intestinal epithelial cells. World J. Gastroenterol., 2011, 17, 2161-2171
3. Li, P.; Waldman, S.A. Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis. Cancer Biol. Ther., 2010, 10, 211-218
4. Liu, Z.; Shi, C.; Yang, J.; Zhang, P.; Ma, Y.; Wang, F.; Qin, H. Molecular regulation of the intestinal epithelial barrier: implication in human diseases. Front. Biosci., 2011, 17, 2903-2909
5. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics CA Cancer J Clin., 2011, 61, 69-90.
6. Grady, W.M. Genomic instability and colon cancer. Cancer Metastasis Rev., 2004, 23, 11-27
7. Cetta, F.; Dhamo, D. Inherited multitumoral syndromes including colorectal carcinoma. Surg. Oncol., 2007, 16, S17-23
8. Joyce, T.; Pintzas, A. Microarray analysis to reveal genes involved in colon carcinogenesis. Expert Opin. Pharmacother, 2007, 8, 895-900
9. Cho, K.R.; Vogelstein, B. Suppressor gene alterations in the colorectal adenoma-carcinoma sequence. J. Cell Biochem., 1992, 16, 137-141
10. Papapolychroniadis, C. Environmental and other risk factors for colorectal carcinogenesis. Tech. Coloproctol., 2004, 8, 7-9
11. Forte, A.; De Sanctis, R.; Leonetti, G.; Manfredelli, S.; Urbano, V.; Bezzi, and M. Dietary chemoprevention of colorectal cancer. Ann. Ita.l Chir., 2008, 79, 261-267
12. Schindler, A.E. Long-term use of progestogens: colon adenoma and colon carcinoma. Gynecol. Endocrinol., 2007, 23, 42-44
13. Barker. N.; Ridgway, R.A, ; van Es J.H.; van de Wetering, M.; Begthel, H.; van den Born, M.; Danenberg, E.; Clarke, A.R.; Sansom, O.J.; Clevers, H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature, 2009, 457, 608-611
14. Kunz-Schughart, L.A.; Knuechel, R. (2002) Tumor-associated fibroblasts (part I): active stromal participants in tumor development and progression? Histol Histopathol., 2002, 17, 599-621
15. Pupa, S.M.; Menard, S.; Forti, S.; Tagliabue, E. New insights into the role of extracellular matrix during tumor onset and progression. J. Cell Physiol., 2002, 192, 259-267
16. Zigrino, P.; Loffek, S.; Mauch, C. Tumor-stroma interactions: their role in the control of tumor cell invasion. Biochimie, 2005, 87, 321-328
17. Micke, P.; Ostman, A. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy. Lung Cancer, 2004, 45 (Suppl 2), S163-175
18. Streuli, C. Extracellular matrix remodelling and cellular differentiation. Curr Opin. Cell Biol., 1999, 11, 634-640
19. Saunders, M.; Iveson, T. Management of advanced colorectal cancer: state of the art. Br. J Cancer, 2006, 95, 131-138.
20. Siegel, R.; Ward, E.; Brawley, O.; Jemal, A. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin., 2011, 61, 212-236
21. Lu, P.; Weaver, V.M.; Werb, Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 2012, 196, 395-406
22. Iozzo, R.V.; Karamanos, N.K. Proteoglycans in health and disease: emerging concepts and future directions. FEBS J., 2010, 277, 3863
23. Theocharis, A.D.; Skandalis, S.S.; Tzanakakis, G.N.; Karamanos, N.K. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J, 2010, 277, 3904-3923
24. Karamanos, N.K.; Tzanakakis, G.N. Glycosaminoglycans: from "cellular glue" to novel therapeutical agents. Curr. Opin. Pharmacol., 2012, Feb 9. [Epub ahead of print]
25. Afratis, N.; Gialeli. C.; Nikitovic, D., Tsegenidis, T., Karousou, E.; Theocharis, A.D.; Pavão, M.S.; Tzanakakis, G.N.; Karamanos, N.K. Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J., 2012, Feb 14. doi: 10.1111/j.1742-4658.2012.08529.x. [Epub ahead of print]
26. Hornebeck, W.; Emonard, H.; Monboisse, J.C.; Bellon, G. Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol., 2002, 12, 231-241
27. Syrokou, A.; Tzanakakis, G.; Tsegenidis, T.; Hjerpe, A.; Karamanos, N.K. Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship. Cell Prolif., 1999, 32, 85-99
28. Nikitovic, D.; Zafiropoulos, A.; Tzanakakis, G.N.; Karamanos, N.K.; Tsatsakis, A.M. Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical compositions. Anticancer Res., 2005, 25, 2851-2856
29. Mueller, M.M.; Fusenig, N.E. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation, 2002, 70, 486-497
30. Mitropoulou, T.N.; Tzanakakis, G.N.; Nikitovic, D.; Tsatsakis, A.; Karamanos, N.K. In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptorpositive and -negative human breast cancer epithelial cells. Anticancer Res., 2002, 22, 2841-2846
31. Chatzinikolaou, G.; Nikitovic, D.; Stathopoulos, E.N.; Velegrakis, G.A.; Karamanos, N.K.; Tzanakakis, G.N. Protein tyrosine kinase and estrogen receptor-dependent pathways regulate the synthesis and distribution of glycosaminoglycans/proteoglycans produced by two human colon cancer cell lines. Anticancer Res., 2007, 27, 4101-4106
32. Wang, C.; Tammi, M.; Guo, H. Tammi, R. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers, Am J Pathol., 148, 1861-1869.
33. Hashimoto, Y.; Skacel, M.; Adams, J.C. Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors. BMC Cancer, 2008, 8:185. doi: 10.1186/1471-2407-8-18
34. Augoff, K.; Rabczynski, J.; Tabola, R.; Czapla, L.; Ratajczak, K.; Grabowski, "Immunohistochemical study of decorin expression in polyps and carcinomas of the colon, " Med Sci. Monit., 2008, 14, CR530-535
35. Weigel, P.H.; Hascall, V.C.; Tammi, M. Hyaluronan synthases. J Biol Chem., 1997, 272, 13997-40000.
36. Itano, N.; Kimata, K. Mammalian hyaluronan synthases. IUBMB Life, 2002, 54, 195-199
37. Csoka, A.; Frost, G.; Stern, R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol., 2001, 20, 499-508
38. Day, A. J.; Prestwich, G. D. J Biol Chem. Hyaluronan-binding proteins: tying up the giant. J. Biol. Chem., 2002, 277, 4585-4588
39. Day AJ, Sheehan JK. Hyaluronan: polysaccharide chaos to protein organisation. Curr. Opin. Struc. Biol., 2001, 11, 617-622
40. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer, 2004, 4, 528-539
41. Blundell, C.D.; Seyfried, N.T.; Day, A.J. Chemistry and Biology of Hyaluronan, Elsevier Science Ltd: Oxford, 2004
42. Blundell, C.D.; Almond, A.; Mahoney, D.J.; DeAngelis, P.L.; Campbell, I.D.; Day, A.J. Towards a structure for a TSG-6.hyaluronan complex by modeling and NMR spectroscopy: insights into other members of the link module superfamily. J. Bio.l Chem., 2005, 280, 18189-18201
43. De Grendele, H.C.; Estess, P.; Siegelman, M.H. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science, 1997, 278, 672-675
44. Toole, B.P.; Hascall, V.C. Hyaluronan and tumor growth. Am J Pathol., 2002, 161, 745-747.
45. Twarock, S.; Tammi, M.I.; Savani, R.C.; Fischer, J.W. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells. J. Bio.l Chem., 2010, 285, 23276-23284
46. Sironen, R.K.; Tammi, M.; Tammi, R.; Auvinen, P.K.; Anttila, M.; Kosma, V.M. Hyaluronan in human malignancies. Exp. Cell Res., 2011, 317, 383-391
47. Ropponen, K.; Tammi, M.; Parkkinen, J.; Eskelinen, M.; Tammi, R.; Lipponen, P.; Agren, U.; Alhava, E.; Kosma, V.M. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res., 1998, 58, 342-347
48. Choi, S.H.; Takahashi, K.; Eto, H.; Yoon, S.S.; Tanabe, K.K. CD44s expression in human colon carcinomas influences growth of liver metastases. Int. J. Cancer, 2000, 85, 523-526
49. Lugli, A.; Zlobec, I. Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer. Mod. Pathol., 2006, 19, 1302-1309
50. Tammi, R.H.; Kultti, A.; Kosma, V.M.; Pirinen, R.; Auvinen, P.; Tammi, M.I. Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin. Cancer Biol., 2008, 18, 288-295
51. Köbel, M.; Weichert, W.; Cruwell, K.; Schmitt, W.D.; Lautenschlager, C.; Hauptmann. S. Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis Virchows Arch. 2004, 445, 456-464
52. Bullard, K.M.; Kim, H.R.; Wheeler, M.A.; Wilson, C.M.; Neudauer, C.L, .; Simpson, M.A.; McCarthy, J.B. Hyaluronan synthase-3 is upregulated in metastatic colon carcinoma cells and manipulation of expression alters matrix retention and cellular growth. Int. J. Cancer, 2003, 107, 739-746
53. Kim, H.R.; Wheeler, M.A, ; Wilson, C.M.; Iida, J., Eng, D.;. Simpson, M.A.; McCarthy, J.B.; Bullard, K.M. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res., 2004, 64, 4569-4576
54. Teng, B.P.; Heffler, M.D.; Lai, E.C.; Zhao, Y.L.; LeVea, C.M.; Golubovskaya, V.M.; Bullarddunn, K.M. Inhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth by increasing apoptosis. Anticancer Agents Med. Chem., 2011, 11, 620-628
55. Jacobson, A.; Rahmanian, M.; Rubin, K.; Heldin, P. Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. Int J Cancer, 2002, 102, 212-219.
56. Liu, D.; Pearlman, E.; Diaconu, E.; Guo, K.; Mori, H.; Haqqi, T.; Markowitz, S.; Willson, J.; Sy, M.S. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc. Natl. Acad. Sci. U S A, 1996, 93, 7832-7783
57. Sironen, R.K.; Tammi, M.; Tammi, R.; Auvinen, P.K.; Anttila, M.; Kosma, and V.M. Hyaluronan in human malignancies. Exp. Cell Res. 2011, 317, 383-91
58. Bouga, H.; Tsouros, I.; Bounias, D.; Kyriakopoulou, D.; Stavropoulos, M.S.; Papageorgakopoulou, N, .; Theocharis, D.A.; Vynios, D.H. Involvement of hyaluronidases in colorectal cancer. BMC Cancer, 2010, 10:499, doi: 10.1186/1471-2407-10-499
59. Laurich, C.; Wheeler, M.A.; Iida, J.; Neudauer, C.L.; McCarthy, J.B.; Bullard, K.M. Hyaluronan mediates adhesion of metastatic colon carcinoma cells. J Surg. Res., 2004, 122, 70-74
60. Misra, S.; Heldin, P.; Hascall, V.C.; Karamanos, N.K.; Skandalis, S.S.; Markwald, R.R.; Ghatak, S. "Hyaluronan-CD44 interactions as potential targets for cancer therapy, " FEBS J., 2011, 278, 1429-1443
61. Alaniz, L.; Rizzo, M, ; Malvicini, M.; Jaunarena, J.; Avella, D.; Atorrasagasti, C., Aquino, J.B.; Garcia, M.; Matar, P., Silva, M.; Mazzolini, G. Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response. Cancer Lett., 2009, 278, 9-16
62. Yamada, Y.; Itano. N.; Narimatsu, H.; Kudo, T.; Morozumi, K.; Hirohashi. S.; Ochiai, A.; Ueda, M.; Kimata, K. Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer. Clin Exp. Metastasis, 2004, 21, 57-6.
63. Yamada, Y.; Itano. N.; Zako, M.; Yoshida, M.; Lenas, P.; Niimi, A.; Ueda, M.; Kimata, K. The gene structure and promoter sequence of mouse hyaluronan synthase 1. Biochem. J., 1998, 330, 1223-1237
64. El-Mezayen, H.A.; Toson, E.S.; Darwish, H.; El-Badry, E. Discriminant function based on parameters of hyaluronic acid metabolism and nitric oxide to differentiate metastatic from non-metastatic colorectal cancer patients. Tumour Biol., 2012 Jan 26. [Epub ahead of print].
65. Misra, S.; Hascall, V.C.; Berger, F.G.; Markwald, R.R.;. Ghatak, S. Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer. Connect. Tissue Res., 2008, 49, 219-224
66. Kim, H.R.; Wheeler, M.A.; Wilson, C.M.; Iida, J.; Eng, D.; Simpson, M.A.; McCarthy, J.B.; Bullard, K.M. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res., 2004, 64, 4569-4576
67. Ropponen, K.M.; Eskelinen, M.J.; Lipponen, P.K.; Alhava, E.; Kosma, V.M. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand. J. Gastroenterol., 1998, 33, 301-309
68. Kopp, R.; Fichter, M.; Schalhorn, G.; Danescu, J.; Classen. S. Frequent expression of the high molecular, 673-bp CD44v3, v8-10 variant in colorectal adenomas and carcinomas. Int. J. Mol. Med., 2009, 24, 677-683
69. Asao, T.; Nakamura, J.; Shitara, Y.; Tsutsumi, S.; Mochiki, E.; Shimura, T.; Takenoshita, S.; Kuwano, H. Loss of standard type of CD44 expression in invaded area as a good indicator of lymph-node metastasis in colorectal carcinoma. Dis. Colon Rectum., 2000, 43, 1250-1254
70. Barshishat, M.; Ariel, A.; Cahalon, L.; Chowers, Y.; Lider, O.; Schwartz, B. TNFalpha and IL-8 regulate the expression and function of CD44 variant proteins in human colon carcinoma cells. Clin. Exp. Metastasis, 2002, 19, 327-337
71. Sleeman, J; Rudy W.; Hofmann, M.; Moll, J.; Herrlich, P.; Ponta, H. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J. Cell Biol., 1996, 135, 1139-1150
72. Ghatak, S.; Misra, S.; Toole, B.P. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J. Biol Chem., 2005, 280, 8875-8883
73. Misra, S.; Obeid, L.M.; Hannun, Y.A.; Minamisawa, S.; Berger, F.G.; Markwald, R.R.; Toole, B.P.; Ghatak, S. Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. J. Biol. Chem., 2008, 283, 14335-143442
74. Misra, S.; Hascall, V.C.; De Giovanni, C.; Markwald, R.R.; Ghatak, S. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE. J. Biol. Chem., 2009, 284, 12432-1446
75. Wu, W.K.; Sung, J.J.; Lee, C.W.; Yu, J.; Cho, C.H. Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Lett., 2010, 295, 7-16
76. Gschwind, A.; Fischer, O.M.; Ullrich, A. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer, 2004, 4, 361-370
77. Misra, S.; Toole, B.P, ; Ghatak, S. Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells. J. Biol. Chem, 2006, 281, 34936-34941
78. Chivasa, S.; Hamilton, J.M.; Pringle, R.S.; Ndimba, B.K.; Simon, W.J.; Lindsey, K.; Slabas, A.R. Proteomic analysis of differentially expressed proteins in fungal elicitor-treated Arabidopsis cell cultures. J. Exp. Bot., 2006, 57, 1553-1562
79. Wang, C.; Entwistle, J.; Hou, G.; Li, Q.; Turley, E.A. The characterization of a human RHAMM cDNA: conservation of the hyaluronan-binding domains. Gene, 1996, 174, 299-306
80. Maxwell, C.A.; McCarthy, J.; Turley, E. Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J. Cell Sci., 2008, 121, 925-932
81. Delpech, B.; Girard, N.; Bertrand, P.; Courel, M.N.; Chauzy, C.; Delpech, A. J Hyaluronan: fundamental principles and applications in cancer. Intern. Med., 1997, 242, 41-48
82. Yamada, Y.; Itano, N.; Narimatsu, H.; Kudo, T.; Hirohashi, S.; Ochiai, A.; Niimi, A.; Ueda, M.; Kimata, K.N. Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction. Jpn. J. Cancer Res., 1999, 90, 987-992
83. Line, A.; Slucka, Z.; Stengrevics, A.; Silina, K.; Li, G.; Rees, R.C. Characterisation of tumour-associated antigens in colon cancer. Cancer Immunol Immunother., 2002, 51, 574-582
84. Zlobec, I.; Baker, K.; Terracciano, L.; Peter, S.; Degen, L.;, Beglinger C.; Lugli, A. Two-marker protein profile predicts poor prognosis in patients with early rectal cancer. Br. J. Cancer, 2008, 99, 1712-1717
85. Zlobec, I.; Terracciano, L.; Tornillo, L.; Günthert, U.; Vuong, T.; Jass, J.R.; Lugli, A. Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer. Gut, 2008, 57, 1413-1419
86. Wu, Y.; Zhao, Q.; Peng, C.; Sun, L.; Li, XF.; Kuang D.M. Neutrophils activation loop. J. Pathol., 2011, 225, 438-447
87. Hascall, V.; Karamanos N. Regulatory roles of hyaluronan in health and disease. FEBS J., 2011, 278, 1411
88. Ponta, H.; Sherman, L.; Herrlich, P.A. CD44: from adhesion molecules to signaling regulators. Nat. Mol. Cell Biol., 2003, 4, 33-45
89. Subramaniam, V.; Vincent, I.R.; Gilakjan, M.; Jothy, S. Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy. Exp. Mol. Pathol., 2007, 83, 332-340
90. Park, Y.S.; Huh, J.W.; Lee, J.H.; Kim, H.R. shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells. Oncol. Rep., 2012, 27, 339-346
91. Kemper, K.; Grandela, C.; Medema, J.P. Molecular identification and targeting of colorectal cancer stem cells. Oncotarget, 2010, 1, 387-395.
92. Cunningham, D.; Humblet, Y.; Siena, S.; et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N. Engl. J. Med., 2004, 351, 337-345
93. Meyerhardt, J.A.; Mayer, R.J. Systemic therapy for colorectal cancer. N. Engl. J Med., 2005, 352, 476-487
94. Mueller, B.M.; Schraufstatter, I.U.; Goncharova, V.; Povaliy, T.; DiScipio, R.; Khaldoyanidi, S.K. Hyaluronan inhibits postchemotherapy tumor regrowth in a colon carcinoma xenograft model. Mol. Cancer Ther., 2010, 9, 3024-3032
95. Lindahl, U.; Kusche-Gullberg, M.; Kjellén, L. Regulated diversity of heparan sulfate. J. Biol. Chem., 1998, 273, 24979-24982
96. Esko, J.D.; Lindahl, U. Molecular diversity of heparan sulfate. Clin. Invest., 2001, 108, 169-173
97. Levy-Adam, F.; Ilan, N.; Vlodavsky, I. Tumorigenic and adhesive properties of heparanase. Semin. Cancer Biol., 2010, 20, 153-160
98. Kreuger J, Spillmann D, Li JP, Lindahl U. Interactions between heparan sulfate and proteins: the concept of specificity. J. Cell Biol. 2006, 174, 323-327
99. Raman, K.; Kuberan, B. Tumor Biology of Heparan Sulfate Proteoglycans. Cur.r Chem. Biol., 2010, 4, 20-31
100. Bret, C.; Moreaux, J.; Schved, J.F.; Hose, D.; Klein, B. SULFs in human neoplasia: implication as progression and prognosis factors. J. Transl. Med., 2011, 9:72. doi: 10.1186/1479-5876-9-72
101. Seko, A.; Nagata, K; Yonezawa, S.; Yamashita, K. Ectopic expression of a GlcNAc 6-O-sulfotransferase, GlcNAc6ST-2, in colonic mucinous adenocarcinoma. Glycobiology, 2002, 12, 379-388
102. Lévy, P.; Munier, A.; Baron-Delage, S.; Chastre, E.; Gespach, C.; Capeau, J.; Cherqui, G. Oncogenic activation of p21ras or pp60c-src in human colonic Caco-2 cells induces post-translation alterations of syndecan-1. Bull Cancer, 1997, 84, 235-237
103. Vlodavsky, I.; Beckhove, P.; Lerner, I.; Pisano, C.; Meirovitz, A.; Ilan, N.; Elkin, M. Significance of Heparanase in Cancer and Inflammation. Cancer Microenviron. 2011, Aug 3. [Epub ahead of print] DOI: 10.1007/s12307-011-0082-7
104. Friedmann, Y.; Vlodavsky, I.; Aingorn, H.; Aviv, A.; Peretz, T.; Pecker, I.; Pappo, O. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Am. J. Pathol., 2000, 157, 1167-1175
105. Doviner, V.; Maly, B.; Kaplan, V.; Gingis-Velitski, S.; Ilan, N.; Vlodavsky, ; Sherman. Y. Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence. Mod. Pathol., 2006, 19, 878-888
106. Waterman, M.; Ben-Izhak, O.; Eliakim, R.; Groisman, G.; Vlodavsky, I.; Ilan, N. Heparanase upregulation by colonic epithelium in inflammatory bowel disease. Mod. Pathol., 2007, 20, 8-14
107. Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer related inflammation. Nature, 2008, 454, 436-444
108. Bollrath, J.; Greten, F.R. IKK/NF-kappaB and STAT3 pathways: central signaling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep., 2009, 10, 1314-1319
109. Danese, S.; Mantovani, A. Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene, 2010, 29, 3313-3323
110. Vlodavsky, I.; Elkin, M.; Pappo, O.; Aingorn, ; H.; Atzmon, R.; Ishai-Michaeli, R.; Aviv, A.; Pecker, I.; Friedmann, Y, Mammalian heparanase as mediator of tumor metastasis and angiogenesis. Isr. Med. Assoc. J, . 2000, 2, 37-45
111. Karibe, T.; Fukui, H.; Sekikawa, A.; Shiratori, K.; Fujimori, T. EXTL3 promoter methylation down-regulates EXTL3 and heparan sulphate expression in mucinous colorectal cancers. J. Pathol., 2008, 216, 32-42
112. Jayson, G.C.; Lyon, M.; Paraskeva, C.; Turnbull, J.E.; Deakin, J.A.; Gallagher, J.T. Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J. Biol. Chem., 1998, 273, 51-57
113. Chatzinikolaou, G.; Nikitovic, D.; Asimakopoulou, A.; Tsatsakis, A.; Karamanos, N.K.; Tzanakakis, G.N. "Heparin-a unique stimulator of human colon cancer cells' growth, " IUBMB Life, 2008, 60, 333-340
114. Flint, N.; Cove, F.L.; Evans, G.S. Heparin stimulates the proliferation of intestinal epithelial cells in primary culture. J. Cell Sci., 1994, 107(2), 401-411
115. Fishman, S.; Brill, S.; Papa, M.; Halpern, Z.; Zvibel, I. "Heparin-derived disaccharides modulate proliferation and Erb-B2-mediated signal transduction in colon cancer cell lines, " Int. J. Cancer, 2002, 99, 179-184
116. Lyon, M.; Deakin, J.A.; Gallagher, J.T. Liver heparan sulfate structure. J. Biol. Chem., 1994, 269, 11208-11215
117. Zvibel, I., Brill, S.; Halpern, Z.; Moskovitz, S.; Yayon, A.; Papa, M. Soluble and matrix-associated heparan sulfate proteoglycans increase expression of erb-B2 and erb-B3 in colon cancer cell lines. Int. J. Cancer, 2001, 91, 316-321
118. Zvibel, I.; Brill, S.; Halpern, Z.; Papa, M. Amphiregulin and hepatocytederived extracellular matrix regulate proliferation and autocrine growth factor expression in colon cancer cell lines of varying liver-colonizing capability. J. Cell Biochem., 1999, 76, 332-340
119. Chatzinikolaou, G.; Nikitovic, D.; Berdiaki, A.; Zafiropoulos, A.; Katonis, P.; Karamanos, N.K.; Tzanakakis, G.N. Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signaling. Cell Prolif., 2010, 43, 9-18
120. Jayson, G.C.; Vives, C.; Paraskeva, C.; Schofield, K.; Coutts, J.; Fleetwood, A.; Gallagher, JT. Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma. Int. J. Cancer, 1999, 82, 298-304
121. Kuniyasu, H.; Oue, N.; Tsutsumi, M.; Tahara, E.; Yasui, W. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3. Clin Cancer Res., 2001, 7, 4067-4072.
122. Sharma, B.; Handler, M.; Eichstetter, I.; Whitelock, J.M.; Nugent, M.A.; Iozzo, R.V. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. Clin Invest., 1998, 102, 15599-15608
123. Park, H.; Kim, Y.; Lim, Y.; Han, I.; Oh, E.S. Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J. Biol. Chem., 2002, 277, 29730-29736
124. Choi, S.; Kim, Y.; Park, H.; Han I.O.; Chung, E.; Lee, S.Y.; Kim, Y.B.; Lee, J.W.; Oh, E.S.; Yi, J.Y. Syndecan-2 overexpression regulates adhesion and migration through cooperation with integrin alpha2. Biochem. Biophys. Res. Commun., 2009, 384, 231-235
125. Lee, H.; Kim, Y.; Choi, Y.; Choi, S.; Hong, E.; Oh, E.S. Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1. Biochem. Biophys. Res. Commun., 2011, 409, 148-153
126. Pap, Z.; Pávai, Z.; Dénes, L.; Kovalszky, I.; Jung, J. An immunohistochemical study of colon adenomas and carcinomas: E-cadherin, Syndecan-1, Ets-1. Pathol. Oncol. Res., 2009, 15, 579-587
127. Mennerich, D.; Vogel, A.; Klaman, I.; Dahl, E.; Lichtner, R.B.; Rosenthal, A.; Pohlenz, H.D.; Thierauch, K.H.; Sommer, A. Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours. Eur. J. Cancer, 2004, 40, 1373-1382
128. Dredge, K.; Hammond, E.; Handley, P.; Gonda, T.J.; Smith, M.T.; Vincent, C.; Brandt, R.; Ferro, V.; Bytheway, I. PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models. Br. J. Cancer, 2011, 104, 635-642
129. Kudchadkar, R.; Gonzalez, R.; Lewis, KD. PI-88: a novel inhibitor of angiogenesis. Expert Opin. Investig. Drugs, 2008, 17(11), 1769-1776
130. Stevenson, J.L.; Varki, A.; Borsig, L Heparin attenuates metastasis mainly due to inhibition of P-and L-selectin, but non-anticoagulant heparins can have additional effects. Thromb. Res., 2007, 120, S107-111
131. Borsig, L.; Wong, R; Feramisco, J, ; Nadeau, D.R.; Varki, N.M.; Varki, A. Heparin and cancer revisited: mechanistic connections involving platelets. Pselectin, carcinoma mucins, and tumor metastasis. PNAS, 2001, 98, 3352-3357
132. Smorenburg, S.M.; Vink, R.; te Lintelo, M.; Tigchelaar, W.; Maas, A.; Büller, H.R.; van Noorden, C.J. In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis. Clin. Exp. Metastasis, 1999, 17, 451-456
133. Lamari, F.N.; Karamanos, N.K. Structure of chondroitin sulfate. Adv. Pharmacol., 2006, 53, 33-48
134. Rohrmann, K.; Niemann, R.; Buddecke, E. Two Nacetylgalactosaminyltransferase are involved in the biosynthesis of chondroitin sulfate. Eur. J. Biochem., 1985, 148, 463-469
135. Ozeran, J.D.; Westley, J.; Schwartz, N.B. Identification and partial purification of PAPS translocase. Biochemistry, 1996, 35, 3695-3703
136. Malmstrom, A., Fransson, L.-A., Hook, M.; Lindahl, U. (1975) Biosynthesis of dermatan sulfate. 1. Formation of L-iduronic acid residues. J. Biol. Chem. 1975, 250, 3419-3425
137. Petit, E.; Delattre, C.; Papy-Garcia, D.; Michaud, P. Chondroitin sulfate lyases: applications in analysis and glycobiology Adv. Pharmacol., 2006, 53, 167-186
138. Kalathas, D.; Theocharis, D.A.; Bounias, D.; Kyriakopoulou, D.; Papageorgakopoulou, N.; Stavropoulos, MS.; Vynios, DH. Chondroitin synthases I, II, III and chondroitin sulfate glucuronyltransferase expression in colorectal cancer. Mol. Med. Report, 2011, 4, 363-368
139. Prabhu, SV.; Bhattacharyya, S.; Guzman-Hartman, G.; Macias, V.; Kajdacsy-Balla, A.; Tobacman, JK. Extra-lysosomal localization of arylsulfatase B in human colonic epithelium. J. Histochem. Cytochem., 2011, 59, 328-335
140. Adany, R.; Heimer, R.; Caterson, B.; Sorrell, J.M.; Iozzo, R.V. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels J. Biol. Chem., 1990, 265, 11389-11396
141. Theocharis, A.D. Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim. Biophys. Acta, 2002, 1588, 165-172
142. Kalathas, D.; Theocharis, D.A.; Bounias, D.; Kyriakopoulou, D.; Papageorgakopoulou, N.; Stavropoulos, M.S.; Vynios, D.H. Alterations of glycosaminoglycan disaccharide content and composition in colorectal cancer: structural and expressional studies. Oncol. Rep., 2009, 22, 369-375
143. Daidouji, K.; Takagaki, K.; Yoshihara, S.; Matsuya, H.; Sasaki, M.; Endo, M.; Neoplastic changes in saccharide sequence of dermatan sulfate chains derived from human colon cancer. Dig. Dis. Sci., 2002, 47, 331-337
144. Mukaratirwa, S.; van Ederen, A.M.; Gruys, E; Nederbragt, H. Versican and hyaluronan expression in canine colonic adenomas and carcinomas: relation to malignancy and depth of tumour invasion. J. Comp. Pathol., 2004, 131, 259-270
145. Yoon, H.; Liyanarachchi, S.; Wright, F.A.; Davuluri, R.; Lockman, J.C.; de la Chapelle, A.; Pellegata, N.S. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53. Proc. Natl. Acad. Sci. U S A, 2002, 99, 15632-15637.
146. Behrens, J. "The role of the Wnt signaling pathway in colorectal tumorigenesis, " Biochem Soc Trans, 2005, 33, 672-675.
147. Xu, L.; Corcoran, R. B.; Welsh J.W.; Pennica, D.; Levine, A. J. Genes Dev., 2000, 14, 585-595
148. Desnoyers, L.; Arnott, D.; Pennica, D. WISP-1 binds to decorin and biglycan. J. Biol. Chem., 2001, 276, 47599-47607
149. Mlakar, V.; Berginc, G.; Volavsek, M.; Stor, Z.; Rems, M.; Glavac, D. Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer. BMC Cancer, 2009, (13), 9:282, doi: 10.1186/1471-2407-9-282
150. Bi, X.; Tong, C.; Dockendorff, A.; Bancroft, L.; Gallagher, L.; Guzman, G.; Iozzo, R.V.; Augenlicht, L.H.; Yang, W. Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. Carcinogenesis, 2008, 29, 1435-1440
151. Bi, X.; Pohl, N.M.; Qian, Z.; Yang, G.R.; Gou, Y.; Guzman, G.; Kajdacsy-Balla, A.; Iozzo, R.V.; Yang, W. Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice. Carcinogenesis, 2012, 33, 326-330
152. Augoff, K.; Rabczynski, J.; Tabola, R.; Czapla, L.; Ratajczak, K.; Grabowski, K. Immunohistochemical study of decorin expression in polyps and carcinomas of the colon. Med. Sci. Monit., 2008, 14, CR530-535
153. Matsuda, Y.; Yamamoto, T.; Kudo, M.; Kawahara, K.; Kawamoto, M.; Nakajima, Y.; Koizumi, K.; Nakazawa, N.; Ishiwata, T.; Naito, Z. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma. Int. J. Oncol., 2008, 33, 1177-1185
154. Seya, T.; Tanaka, N.; Shinji, S.; Yokoi, K, .; Koizumi, M.; Teranishi, N; Yamashita, K.; Tajiri, T.; Ishiwata, T.; Naito, Z Lumican expression in advanced colorectal cancer with nodal metastasis correlates with poor prognosis. Onco. Rep., 2006, 16, 1225-1230
155. Gu, X.; Ma, Y.; Xiao, J.; Zheng, H.; Song, C.; Gong, Y.; Xing, X. Upregulated biglycan expression correlates with the malignancy in human colorectal cancers. Clin. Exp. Med., 2011, doi: 10.1007/s10238-011-0155-4 [Epub ahead of print]
156. Iozzo, R.V.; Cohen, I. Altered proteoglycan gene expression and the tumor stroma. Experientia, 1993, 49, 447-455
157. Hauptmann, S.; Siegert, A.; Berger, S.; Denkert, C.; Köbel, M.; Ott, S.; Siri A.; Borsi, L. Regulation of cell growth and the expression of extracellular matrix proteins in colorectal adenocarcinoma: a fibroblast-tumor cell coculture model to study tumor-host interactions in vitro. Eur J Cell Biol., 2003, 82, 1-8.
158. Iozzo RV. Neoplastic modulation of extracellular matrix. Colon carcinoma cells release polypeptides that alter proteoglycan metabolism in colon fibroblasts. J. Biol. Chem., 1985, 260, 7464-7473
159. Adany, R.; Heimer, R.; Caterson, B.; Sorrell, J.M. and Iozzo R.V. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. J. Biol. Chem., 1990, 265, 11389-11396
160. Hauptmann, S.; Zardi, L.; Siri, A.; Carnemolla, B.; Borsi, L.; Castellucci, M.; Klosterhalfen, B.; Hartung, P.; Weis, J.; Stöcker, G. et al. Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms. Lab. Invest., 1995, 73, 172-182
161. Seya, T.; Tanaka, N.; Shinji, S.; Yokoi, K.; Koizumi, M.; Teranishi, N.; Yamashita, K.; Tajiri, T.; Ishiwata, T.; Naito, Z. Lumican expression in advanced colorectal cancer with nodal metastasis correlates with poor prognosis. Oncol. Rep., 2006, 16, 1225-1230
162. Coulson-Thomas, V.J.; Coulson-Thomas, Y.M.; Gesteira, T.F.; de Paula, C.A.; Mader, A.M.; Waisberg, J.; Pinhal, M.A.; Friedl, A.; Toma, L.; Nader, H.B. Colorectal cancer desmoplastic reaction up-regulates collagen synthesis and restricts cancer cell invasion. Cell Tissue Res., 2011, 346, 223-236
163. Saadi, A.; Shannon, N.B.; Lao-Sirieix, P; O'Donovan, M.; Walker, E.; Clemons, N.J.; Hardwick, J.S.; Zhang, C.; Das, M.; Save, V.; Novelli, M.; Balkwill, F.; Fitzgerald, RC. Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. Proc. Natl. Acad. Sci. U S A, 2010, 107, 2177-2182
164. Mukaratirwa, S.; Koninkx, J.F.; Gruys, E.; Nederbragt, H. Mutual paracrine effects of colorectal tumour cells and stromal cells: modulation of tumour and stromal cell differentiation and extracellular matrix component production in culture. Int. J Exp. Pathol., 2005, 86, 219-229
165. Caporale, A.; Amore Bonapasta, S.; Scarpini, M.; Ciardi, A, ; Vestri, A.; Ruperto, M.; Giuliani, A. Quantitative investigation of desmoplasia as a prognostic indicator in colorectal cancer. J. Invest. Surg., 2010, 23, 105-109
166. Ueno, H.; Jones, A.M.; Wilkinson, K.H.; Jass, J.R.; Talbot, I.C. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut, 2004, 53, 581-586
167. Halvorsen, T.B.; Seim, E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J. Clin. Pathol, . 1989, 42, 162-166.